California 2025-2026 Regular Session

California Assembly Bill AB1503

Introduced
2/24/25  
Refer
3/13/25  
Report Pass
4/21/25  
Refer
4/22/25  
Report Pass
4/29/25  
Refer
5/1/25  
Refer
5/21/25  
Report Pass
5/23/25  
Engrossed
6/2/25  
Refer
6/3/25  
Refer
6/11/25  
Report Pass
7/16/25  
Refer
7/17/25  
Refer
8/18/25  
Report Pass
8/29/25  

Caption

Pharmacy.

Impact

AB 1503 introduces several changes that could enhance the operational capacity of pharmacies, particularly those located in medically underserved areas. The bill allows for the waiver of license application fees for these pharmacies, potentially increasing access to pharmacy services in those areas. Furthermore, it expands the number of pharmacy technicians that a pharmacist can supervise, increasing capacity for service provision. The bill also aims to clarify the authority pharmacists have in performing certain healthcare functions without a prescription under specific conditions, promoting preventive healthcare.

Summary

Assembly Bill No. 1503, introduced by Assembly Member Berman, aims to amend various sections of the Business and Professions Code relating to the practice of pharmacy in California. The bill asserts that the California State Board of Pharmacy retains exclusive authority to administer and enforce the Pharmacy Law, particularly in licensing pharmacists and pharmacies. A significant aspect of this bill is the extension of the board’s provisions until January 1, 2030, ensuring continued regulation within the pharmacy sector. Additionally, it mandates the establishment of a Pharmacy Technician Advisory Committee to advise the board on relevant matters.

Sentiment

The sentiment surrounding AB 1503 appears to be largely favorable among healthcare providers and advocates for expanding access to pharmacy services, especially in underserved communities. Supporters argue that these changes will improve healthcare delivery and public health outcomes through enhanced pharmacy access and service capabilities. However, some concern may exist regarding the balance between expanding pharmacist responsibilities and maintaining patient safety, as increased workload may pose challenges for quality assurance.

Contention

Despite the overall positive reception, there may be contentions regarding the bill's provisions, particularly concerning the regulatory oversight and the potential implications for pharmacy operations. Critics may argue that while increasing the scope of practice for pharmacists and pharmacy technicians may benefit patients, it requires rigorous oversight to prevent potential misuse or errors. Moreover, the bill's measures to fine pharmacies for non-compliance with the law intend to deter malpractice, yet could lead to apprehensions about the financial implications for smaller pharmacy operations.

Companion Bills

No companion bills found.

Previously Filed As

CA SB524

Pharmacists: furnishing prescription medications.

CA AB425

Medi-Cal: pharmacogenomic testing.

CA AB1286

Pharmacy.

CA SB966

Pharmacy benefits.

CA AB3063

Pharmacies: compounding.

CA AB1341

Public health: oral therapeutics.

CA AB3026

Pharmacy.

CA AB913

Pharmacy benefit managers.

CA AB663

Pharmacy: mobile units.

CA AB782

Pharmacies: compounding.

Similar Bills

No similar bills found.